Member Login
RoboForm fills in forms so you don't have to

Forgot your password? Click here to reset your password.

RespiteMatch.com Health Blog

News, Opinions and Advice regarding the U.S. Home Health Care Industry

Currently browsing Health Care News

Health Care Industry News

CDC says more shots are expected to be available in the next few weeks

October 19th, 2006 by RespiteMatch.com

By PATRICIA ANSTETT
FREE PRESS MEDICAL WRITER

October 18, 2006

The nation’s flu supplies are adequate and 35 million more doses should arrive in the next six weeks, time to vaccinate anyone to avoid getting sick before the season peaks early next year, a top federal immunization official said Thursday.
Read the rest of this entry »

Use of stents to prevent strokes discouraged

October 19th, 2006 by RespiteMatch.com

By Thomas H. Maugh II and Denise Gellene
Los Angeles Times

The increasingly common practice of preventing strokes by using wire-mesh stents to prop open neck arteries is much riskier than the traditional method of surgically removing plaque and should be curtailed, according to two large European studies.
Read the rest of this entry »

Parkinson’s therapy trial success

October 18th, 2006 by RespiteMatch.com

Gene therapy has been shown to have “significant” clinical benefits for people with Parkinson’s disease, according to a study.
The small-scale trial showed the 12 patients’ symptoms improved by up to 65% after a year, with no ill effects.

The trial was carried out by biotech company Neurologix Inc, based in the United States.

Steve Ford, chief executive of the Parkinson’s Disease Society, described the results as “encouraging”.
Read the rest of this entry »

Taxotere Approved for Head and Neck Cancer

October 18th, 2006 by RespiteMatch.com

10.18.06, 12:00 AM ET

WEDNESDAY, Oct. 18 (HealthDay News) — Taxotere (docetaxel) has received expanded approval to treat cancer of the head and neck, which accounts for about 3 percent of all cancer cases in the United States, the U.S. Food and Drug Administration said Wednesday.
Read the rest of this entry »

Study Finds a Widespread Risk of Reactions to Some Medicines

October 18th, 2006 by RespiteMatch.com

By THE ASSOCIATED PRESS
CHICAGO, Oct. 17 (AP) — Harmful reactions to medicines, usually attributed to accidental overdoses and allergic reactions, send more than 700,000 Americans to emergency rooms each year, government research shows.

People over 65 faced the greatest risks.

The results, from 2004-5, represent the first two years of data from a national surveillance project on outpatient drug safety. The project was developed by the federal Centers for Disease Control and Prevention, the Food and Drug Administration and the United States Consumer Product Safety Commission. Read the rest of this entry »

Holy mackerel! Fish is good for you

October 18th, 2006 by RespiteMatch.com

Wednesday, October 18, 2006

By Elizabeth Bernstein, The Wall Street Journal

Health-conscious consumers have long been vexed by whether the health benefits of seafood outweigh the risks from toxic substances, such as mercury. Now, two large federally-funded studies have weighed the evidence and reached a definitive conclusion: Eat fish.
Read the rest of this entry »

Vitamin D Retards Breast Cancer Progression

October 17th, 2006 by RespiteMatch.com

By Crystal Phend, MedPage Today Staff Writer
Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco
October 17, 2006

Review
LONDON, Oct. 17 — There’s more evidence suggesting that vitamin D may be protective against breast cancer progression, but the relationship remains less than definitive, researchers here said.

Serum levels of 25-hydroxyvitamin D, the major circulating form of vitamin D, were significantly higher in patients with locally advanced or metastatic breast cancer compared with those who had early-stage disease, according to a study reported online in the Journal of Clinical Pathology.
Read the rest of this entry »

FDA approves new type of diabetes drug

October 17th, 2006 by RespiteMatch.com

Tue Oct 17, 2006 5:23 PM BST

By Susan Heavey

WASHINGTON (Reuters) - A new diabetes drug that helps the body control blood sugar won U.S. approval on Tuesday, making it the first in a new class of pills that treat the disease without the weight gain seen with some other drugs.
Read the rest of this entry »

Fake diabetic blood test strips warning

October 16th, 2006 by RespiteMatch.com

Posted: Saturday, October 14, 2006

Washington

US health officials warned diabetics not to use counterfeit blood sugar test strips that were distributed nationwide and could provide inaccurate results.
Read the rest of this entry »

Breast cancer rates double in 20 years

October 16th, 2006 by RespiteMatch.com

October 16, 2006

NEW figures show breast cancer rates have doubled in 20 years but still not enough women are having regular mammograms Health Minister Tony Abbott says.

While new figures showed more women were surviving the leading cause of female cancer deaths, Mr Abbott said statistics showed only 56 per cent of women were having regular mammograms.
Read the rest of this entry »

U.S. OKs Alzheimer’s drug to treat severe dementia

October 14th, 2006 by RespiteMatch.com

Fri Oct 13, 2006 9:28 PM BST

WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday cleared Eisai Co. Ltd.’s blockbuster Alzheimer’s drug, Aricept, to treat severe dementia in patients with the degenerative brain disease.
Read the rest of this entry »

Cattle ranch tied to E. coli source

October 14th, 2006 by RespiteMatch.com

Exact strain of bacteria in outbreak found in dung near spinach field.

By Dorsey Griffith - Bee Medical Writer
Published 12:00 am PDT Friday, October 13, 2006

Cow dung from a cattle operation next to a spinach field implicated in the recent E. coli outbreak has tested positive for the exact same strain that sickened 199 people and killed three in the United States in recent weeks, federal and state health officials announced Thursday. Read the rest of this entry »

Lucentis Stalls Blood Vessel Growth in Macular Degeneration

October 5th, 2006 by RespiteMatch.com

By Judith Groch, MedPage Today Staff Writer
Reviewed by Rubeen K. Israni, M.D., Fellow, Renal-Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine
October 04, 2006

Review
MIAMI, Oct. 5 — Lucentis (ranibizumab) is an effective treatment for neovascular age-related macular degeneration, according to two large randomized controlled trials.

One of the reports found that over two years, on average, patients receiving injections of Lucentis gained more than one line of visual acuity on a standard eye chart, whereas those receiving sham injections lost more than two lines.

Read the rest of this entry »

Didn’t expect to win the Nobel Prize so soon’: Nobel laureates

October 3rd, 2006 by RespiteMatch.com

STOCKHOLM - This year’s Nobel Medicine Prize laureates, US researchers Andrew Fire and Craig Mello, said Monday they were shocked to receive the prestigious award just eight years after making the discovery for which they were honoured.
Read the rest of this entry »

Seniors at risk from drug plan gap

October 2nd, 2006 by RespiteMatch.com

A UH researcher finds that 28% cut back on medications when coverage changed
By Helen Altonn
haltonn@starbulletin.com
Seniors could cut back on or stop medications after a Medicare health plan stops covering brand-name drugs, falling into a gap nicknamed the doughnut hole, a Hawaii researcher reports.
Read the rest of this entry »